CompleWare and VIDA Announce Joint Marketing Agreement for Respiratory Trials

Wednesday, September 27, 2017 Respiratory Disease News
Email Print This Page Comment bookmark
Font : A-A+

IOWA CITY, Iowa, Sept. 26, 2017 /PRNewswire/ -- CompleWare and VIDA announce a joint marketing agreement promoting complementary

respiratory services. Their partnership will deploy a best-in-class pulmonary platform and excellence in clinical trial management, with precision, ISO-certified core lab imaging. 

"CompleWare and VIDA provide unique service offerings in the

respiratory therapeutic area," said Dr. John M. Weiler, CompleWare's President. "Their synergy will lead to a strong joint value proposition to customers."

CompleWare software and contract research organization (CRO) services will facilitate complete respiratory development programs. This will provide specialized and insightful experts to support global respiratory trials. VIDA and CompleWare will provide precision lung imaging informatics, delivered through core lab imaging services (Precision Services) and interactive software (VIDA|vision®). This solution spans the care cycle, from detection through treatment across a range of pulmonary diseases: COPD (including severe emphysema, chronic bronchitis), lung cancer, and asthma.

CompleWare and VIDA offer unprecedented pulmonary expertise. CompleWare has provided services to the pharmaceutical industry for the collection and management of clinical trial data for >30 years. Drawing on multi-disciplinary expertise in pulmonology, radiology, and electrical and biomedical engineering, VIDA has become an innovator in precision pulmonary imaging.  VIDA has supported numerous academic and industry trials for >10 years, cited in >200 peer-reviewed publications.

The CompleClinical® application is a comprehensive eClinical solution for clinical trial data capture and management. The VIDA|vision pulmonary suite of software and services provides unparalleled breadth and depth of analysis, empowering chest physicians with advanced, quantitative information to help inform care decisions. 

"We are thrilled to be partnering with CompleWare, merging our advanced quantitative lung imaging with expert respiratory trial management to offer a great dynamic to meet the endpoints of tomorrow's pulmonary medicine," said Jered Sieren, Director of Clinical Research & Development at VIDA.

About CompleWare CompleWare is a full service CRO and software vendor for the clinical trials industry. For more information, visit www.compleware.com.

About VIDAVIDA focuses on changing the practice of pulmonary care with data-driven, personalized services that aid early detection, evaluation, and treatment planning for lung diseases, including lung cancer, obstructive airway diseases, and asthma.  VIDA's software and services are cleared for clinical use in the United States, Canada, European Union, and Australia.  VIDA is headquartered in Coralville, IA, with an additional office in Minneapolis, MN. More at www.vidadiagnostics.com.

 

View original content:http://www.prnewswire.com/news-releases/compleware-and-vida-announce-joint-marketing-agreement-for-respiratory-trials-300526106.html

SOURCE CompleWare; VIDA



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store